Literature DB >> 35947200

Characterization of Sequence Types and Mechanisms of Resistance to Tigecycline Among Acinetobacter baumannii Isolated from Children.

Zohreh Ghalavand1,2, Gita Eslami2, Ali Hashemi2, Mehrzad Sadredinamin2, Neda Yousefi2, Razieh Dehbanipour3.   

Abstract

The present study aimed to investigate the mechanisms of resistance to tigecycline and to determine sequence types of Acinetobacter baumannii isolates recovered from children, using the Multilocus Sequence Typing (MLST). A total of 74 A. baumannii isolates were recovered from patients at one of the children's hospital in Tehran, Iran. Antimicrobial susceptibility testing of the isolates was performed for different classes of antibiotics and minimum inhibitory concentrations of colistin and tigecycline were determined using broth microdilution method and E-test strips, respectively. The presence of ISAba1, AbaR, tet(39), and tetX and the expressions of adeB, adeG, and adeJ efflux pump genes were measured using Polymerase Chain Reaction (PCR) and quantitative real-time PCR (RT-PCR), respectively. The diversity of mutations across the regulatory genes of RND efflux pumps (adeRS, adeL, and adeN) and trm gene were determined using their PCR amplification and DNA sequencing in tigecycline-resistant isolates. In addition, STs of tigecycline-resistant isolates were determined using MLST method. Three A. baumannii isolates were resistant to tigecycline. Several amino acid substitutions were identified in AdeRS, AdeN, and Trm but no alteration was found in AdeL. Nevertheless, adeB, adeG, and adeJ overexpression were observed in 1, 2, and 1 isolates, respectively. The tigecycline-resistant isolates belonged to ST1720 and ST2285. This is the first study reporting on ST2285 in A. baumannii populations. Among 74 isolates, two tigecycline susceptible isolates carried tet(39) gene but no tetX gene was detected. We concluded that mutations in regulatory genes of RND efflux pumps and the trm gene may play some important role in A. baumannii resistance to tigecycline.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35947200     DOI: 10.1007/s00284-022-02976-5

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.343


  27 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Plasmid borne Carbapenem-Hydrolyzing Class D β-Lactamases (CHDLs) and AdeABC efflux pump conferring carbapenem-tigecycline resistance among Acinetobacter baumannii isolates harboring TnAbaRs.

Authors:  Mohammad Savari; Alireza Ekrami; Saeed Shoja; Abbas Bahador
Journal:  Microb Pathog       Date:  2017-01-27       Impact factor: 3.738

3.  Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.

Authors:  Bahare Salehi; Hossein Goudarzi; Bahram Nikmanesh; Hamidreza Houri; Mostafa Alavi-Moghaddam; Zohreh Ghalavand
Journal:  J Infect Chemother       Date:  2018-03-16       Impact factor: 2.211

4.  Diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii.

Authors:  Stefanie Gerson; Jennifer Nowak; Esther Zander; Julia Ertel; Yurong Wen; Oleg Krut; Harald Seifert; Paul G Higgins
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

Review 5.  Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.

Authors:  Wentao Ni; Yuliang Han; Jin Zhao; Chuanqi Wei; Junchang Cui; Rui Wang; Youning Liu
Journal:  Int J Antimicrob Agents       Date:  2015-12-13       Impact factor: 5.283

6.  Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.

Authors:  Qiong Chen; Xi Li; Hua Zhou; Yan Jiang; Yan Chen; Xiaoting Hua; Yunsong Yu
Journal:  J Antimicrob Chemother       Date:  2013-08-08       Impact factor: 5.790

7.  Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.

Authors:  C Rumbo; E Gato; M López; C Ruiz de Alegría; F Fernández-Cuenca; L Martínez-Martínez; J Vila; J Pachón; J M Cisneros; J Rodríguez-Baño; A Pascual; G Bou; M Tomás
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

8.  Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital.

Authors:  Mei Deng; Man-Hua Zhu; Jun-Jie Li; Sheng Bi; Zi-Ke Sheng; Fei-Shu Hu; Jia-Jie Zhang; Wei Chen; Xiao-Wei Xue; Ji-Fang Sheng; Lan-Juan Li
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

9.  A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii.

Authors:  Jun-Ren Sun; Cherng-Lih Perng; Ming-Chin Chan; Yuji Morita; Jung-Chung Lin; Chih-Mao Su; Wei-Yao Wang; Tein-Yao Chang; Tzong-Shi Chiueh
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 10.  Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.

Authors:  Muhammad Asif; Iqbal Ahmad Alvi; Shafiq Ur Rehman
Journal:  Infect Drug Resist       Date:  2018-08-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.